These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2900711)

  • 1. Pharmacotherapy of the hospitalized young adult schizophrenic patient.
    Zito JM; Craig TJ; Wanderling J; Siegel C; Green M
    Compr Psychiatry; 1988; 29(4):379-86. PubMed ID: 2900711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacoepidemiology of treatment-refractory schizophrenia.
    Collins EJ; Hogan TP; Awad AG
    Can J Psychiatry; 1992 Apr; 37(3):192-5. PubMed ID: 1350502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaco-epidemiology in 136 hospitalized schizophrenic patients.
    Zito JM; Craig TJ; Wanderling J; Siegel C
    Am J Psychiatry; 1987 Jun; 144(6):778-82. PubMed ID: 3592000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT
    Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology in the secondary and tertiary prevention of mental illness.
    Ban TA
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():403-8. PubMed ID: 45168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in patients with schizophrenia.
    McCue RE; Waheed R; Urcuyo L
    J Clin Psychiatry; 2003 Sep; 64(9):984-9. PubMed ID: 14628972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.
    Gaertner I; Gilot C; Heidrich P; Gaertner HJ
    Pharmacopsychiatry; 2002 Mar; 35(2):37-43. PubMed ID: 11951144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients.
    Dinakar HS; Sobel RN; Bopp JH; Daniels A; Mauro S
    Psychiatr Serv; 2002 Jun; 53(6):755-7. PubMed ID: 12045315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia.
    Glick ID; Pham D; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1261-5. PubMed ID: 16965205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
    Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.
    Wu YH; Lai CY; Chang YS
    Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacologic treatment of negative schizophrenic symptoms.
    Opler LA; Albert D; Ramirez PM
    Compr Psychiatry; 1994; 35(1):16-28. PubMed ID: 7908618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
    Kurylev AA; Brodyansky VM; Andreev BV; Kibitov AO; Limankin OV; Mosolov SN
    Psychiatr Danub; 2018 Jun; 30(2):157-163. PubMed ID: 29930225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic.
    Malla AK; Norman RM; Scholten DJ; Zirul S; Kotteda V
    J Clin Psychiatry; 2001 Mar; 62(3):179-84. PubMed ID: 11305704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
    Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
    Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia.
    dosReis S; Zito JM; Buchanan RW; Lehman AF
    Schizophr Bull; 2002; 28(4):607-17. PubMed ID: 12795494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
    Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial.
    Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G
    J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.